Science & Enterprise subscription

Follow us on Twitter

  • A new company developing treatments to relieve allergic reactions with reprogrammed antibodies began work and is ra… https://t.co/LFNVxych8d
    about 4 hours ago
  • New post on Science and Enterprise: New Allergy Biotech Launches, Raises $10M https://t.co/x5W0TwnCBu #Science #Business
    about 4 hours ago
  • Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 inf… https://t.co/LaUrUiRmhk
    about 23 hours ago
  • New post on Science and Enterprise: Trial Set for Covid-19 Antibodies in Long-Term Care https://t.co/tF0a7CDgGr #Science #Business
    about 23 hours ago
  • The numbers of vaccine candidates in development and clinical trials show modest but steady growth, now up to 157 a… https://t.co/AO2DxxTgF8
    about 1 day ago

Please share Science & Enterprise

Trial Set for Covid-19 Antibodies in Long-Term Care

Mobile lab team

Two companies and NIH are beginning a clinical trial of synthetic antibodies to both treat and prevent Covid-19 infections among people in long-term care. . . . → Read More: Trial Set for Covid-19 Antibodies in Long-Term Care

Trial Testing Lymphoma Drug to Treat Covid-19

SARS-Cov-2 virus

A clinical trial is underway testing an experimental drug for lymphoma and neurological disorders also as a treatment for early Covid-19 infections. . . . → Read More: Trial Testing Lymphoma Drug to Treat Covid-19

Oxford Covid-19 Vaccine Trial Invokes Immune Responses

Syrine ingloved hand

Results from a clinical trial testing a Covid-19 vaccine show the vaccine invokes two types of immune responses without serious adverse effects. . . . → Read More: Oxford Covid-19 Vaccine Trial Invokes Immune Responses

New Company Offers A.I. Aging Biomarker Analysis

Older couple

A new enterprise is underway using artificial intelligence to analyze a person’s body chemistry and calculate the likelihood of age-related diseases. . . . → Read More: New Company Offers A.I. Aging Biomarker Analysis

Immune Responses Shown in Covid-19 Nasal Vaccine

Nasal spray

An experimental vaccine to prevent Covid-19 infections, given as a nasal spray, produces immune responses in tests with lab mice. . . . → Read More: Immune Responses Shown in Covid-19 Nasal Vaccine

Cannabis Assessed for Pain in Real-World Trial

Cannabis plant

A clinical trial in Canada is evaluating medical cannabis products as treatments for chronic pain with participants reporting their experiences online. . . . → Read More: Cannabis Assessed for Pain in Real-World Trial

Pharma Companies Form $1B Antibiotics Fund

Klebsiella pneumoniae

A group of 23 pharmaceutical companies are creating an investment fund to finance research and development of new drugs to combat antibiotic resistance. . . . → Read More: Pharma Companies Form $1B Antibiotics Fund

Virtual Drug Discovery Incubator Launched for Univ. Labs

Lab jars and beakers

Life science investors and a drug discovery company started a remote business incubator service to discover and develop early therapy candidates from academic research. . . . → Read More: Virtual Drug Discovery Incubator Launched for Univ. Labs

Open-Source N95 Respirator Mask in the Works

Open source N95 mask

An engineering partnership is designing a 3-D printed medical face mask needed by front-line health care workers, with its specifications soon to be made freely available. . . . → Read More: Open-Source N95 Respirator Mask in the Works

Program Reduces Long-Term Care Covid-19 Outbreaks

Hands on lap

A collaborative program between an academic medical center and long-term care homes for older residents helps reduce Covid-19 infection outbreaks and deaths. . . . → Read More: Program Reduces Long-Term Care Covid-19 Outbreaks